CTLA4 and cancer: This study observed that aberrant expression of IRGs is correlated with cancer development, and the high-risk group showed higher TMB, immune cell infiltration, PD-1, PDL1, and CTLA4 expression, and an intensive immune-related phenotype compared to the low-risk group.